The real test for healthtech companies isn’t innonvation, it’s implementation

The last article published on PharmaPhorum explores how the pharmaceutical industry is moving from discussing digital transformation to implementing it at scale. 

Co-authored by Ursula Costa, Director of Innovation and Investment at DayOne, and Caoimhe Vallely-Gilroy, Managing Director of the health.tech global summit and pharmaceutical executive and clinical strategy specialist in digital health, the article highlights the Basel region as an emerging healthtech and life sciences “supercluster,” where pharma, AI, biotech, and digital health are converging to turn innovation into real-world healthcare solutions. 

The articles explores how organizations are shifting their focus from experimentation to execution, with increasing emphasis on integrating AI and digital tools into clinical development, healthcare systems, and pharmaceutical R&D. Basel’s collaborative ecosystem,  supported by initiatives such as DayOne and the Basel Area Life Sciences Supercluster Healthtech ecosystem — is presented as a model for how innovation can be validated, scaled, and operationalised across the healthcare industry. 

The article also references discussions from the 2026 health.tech global summit in Basel, where industry leaders focused on the growing need to move beyond AI pilot projects and embed scalable technologies into real healthcare and pharmaceutical environments.